ProPhase Labs Inc (NASDAQ:PRPH) is pursuing a $50 million cash recovery from COVID-19 receivables through Crown Medical Collections, which could significantly boost the company's market cap. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results